SM
CRVO icon

Sabby Management’s CervoMed CRVO Stock Holding History

Sabby Management’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14,473
Closed -$500K – 92
2019
Q4 		$500K Buy
14,473
+8,235
+132% +$503K 0.14% 35
2019
Q3 		$865K Sell
6,238
-10
-0.2% -$1.61K 0.47% 26
2019
Q2 		$1.34M Buy
+6,248
New +$1.68M 1.68% 14

Other funds holding CRVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SRCM
Swift Run Capital Management Charlottesville, Virginia $51.8M AUM 6.71% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

Sabby Management's CRVO Position: Q1 2020 in Review

Sabby Management sold out of CervoMed (CRVO) in Q1 2020, closing a stake of 14,473 shares — an estimated $500K sold.

Sabby Management first reported a position in CRVO in Q2 2019 and held it in 3 quarters. The position peaked at $1.34M in Q2 2019. 17 funds tracked by Wall St. Rank hold CRVO as of Q1 2020.

  • Sabby Management reported no remaining CervoMed position as of Q1 2020 after selling out during the quarter.
  • Sabby Management sold 14,473 CervoMed shares in Q1 2020, an estimated $500K.
  • Sabby Management first reported a position in CervoMed in Q2 2019 and held it in 3 quarters.
  • Sabby Management's CervoMed position peaked at $1.34M in Q2 2019.
  • 17 funds tracked by Wall St. Rank held CervoMed as of Q1 2020.

Based on Sabby Management's 13F filing for Q1 2020, filed 15 May 2020.